CE approved Lung health screening solution that covers TB, Pneumonia & 21 other lung conditions. Works offline/online ideal for screening or hospital facilities

About DeepTek

Incorporated in the U.S. in 2017, DeepTek is among the few medical imaging AI start-ups that have successfully achieved commercial adoption of AI technology in clinical practice—creating clear, quantifiable value for patients, hospitals, and radiologists.

DeepTek’s vision is to bridge the significant gaps in the imaging sector by delivering cutting-edge solutions powered by deep learning algorithms. Its products have received multiple regulatory approvals, including the coveted US FDA clearance.

DeepTek currently serves over 500 hospitals across India, Singapore, Thailand, the Philippines, Nigeria, Kenya, and several other countries. Its Chest X-ray AI solution has been deployed at 325+ sites globally for TB screening, with over two million individuals screened to date. In Singapore, DeepTek's solution has been adopted as the National Radiology AI platform.

About CXR AI Solution

DeepTek’s CXR AI solution is a WHO-recommended tool designed to detect Tuberculosis and 21 other critical lung conditions with speed and precision—enabling early intervention, reducing disease burden, and improving outcomes at scale. A key differentiator is its ability to interpret pediatric chest X-rays, including the detection of pediatric TB and pneumonia—addressing a crucial diagnostic gap in younger populations often underserved by conventional AI models. DeepTek’s CXR AI solution has already screened over 2 million individuals across 325+ sites in 8+ countries.

Cleared by the US FDA and CE marked in recognized regions, the solution is approved for use in both adult and pediatric populations aged 4 years and above. By accelerating diagnosis, improving radiologist productivity, and supporting high-quality care delivery, this AI-powered platform is helping healthcare systems make lung health screening more accessible, scalable, and impactful—particularly in the global fight against TB.